^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Mantle Cell Lymphoma |
| Drug: | Ayvakit (avapritinib) (CSF-1R inhibitor, PDGFR antagonist, mutant c-KIT inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
06/16/2021
Excerpt:
YVAKIT is a kinase inhibitor indicated for… the treatment of adult patients…and mast cell leukemia (MCL).
